RCUS ARCUS BIOSCIENCES
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 19 analyst firms say about ARCUS BIOSCIENCES: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
17 rated views · 19 analyst/firm records · 19 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8078
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8057
Recent analyst activity · last 90 days
Our tracked history has 15 reports on RCUS from 10 analyst firms in the last 90 days (19 firms in the past year).
Comparing each firm's latest target with its previous one: 3 raised their price target, 2 lowered it and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: SVB Leerink raised its target from $47.00 (set 20 Apr 2026) to $49.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Jason Zemansky | Hold | 28 Nov 2025 | 26.00 USD |
| Cantor Fitzgerald | Li Watsek | Buy | 15 Jun 2026 | — |
| Citigroup | Yigal Nochomovitz | Buy | 21 Oct 2026 | 50.00 USD |
| Evercore ISI | Umer Raffat | Buy | 3 Mar 2026 | 33.00 USD |
| Goldman Sachs | Richard Law | Buy | 7 Aug 2026 | 42.00 USD |
| H.C. Wainwright | Emily Bodnar | Buy | 20 Jul 2026 | 45.00 USD |
| JPMorgan | Priyanka Grover | Buy | 14 Oct 2026 | 41.00 USD |
| Leerink Partners | Daina M Graybosch | Buy | 2 Mar 2026 | Conflicting reports · excluded |
| Lifesci Capital | Charles Zhu | Buy | 4 Jun 2026 | 46.00 USD |
| Mizuho | Salim Syed | Buy | 24 Mar 2026 | 47.00 USD |
| Morgan Stanley | Terence Flynn | — | 10 Aug 2026 | 23.00 USD |
| TD Cowen | Tara Bancroft | Buy | 16 Sep 2026 | — |
| Truist | Supawat Thongthip | Buy | 21 Oct 2026 | 41.00 USD |
| UBS | Unnamed analyst | Buy | 15 Dec 2025 | — |
| Wedbush | Robert Driscoll | Buy | 21 Oct 2026 | 49.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Eva Fortea-Verdejo | Hold | 6 Aug 2026 | 26.00 USD |
| William Blair | Alethia Young | Buy | 16 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:52 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.